Predictors of ectopic fat accumulation in liver and pancreas in obese men and women

Obesity

Volumn 19, Issue 9, 2011, Pages 1747-1754

  Rossi, Andrea P ^a   Fantin, Francesco ^a   Zamboni, Giulia A ^a   Mazzali, Gloria ^a   Rinaldi, Caterina A ^a   Del Giglio, Micol ^a   Di Francesco, Vincenzo ^a   Barillari, Marco ^a   Pozzi Mucelli, Roberto ^a   Zamboni, Mauro ^a  

^a UNIVERSITY OF VERONA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; ALANINE AMINOTRANSFERASE; C REACTIVE PROTEIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LEPTIN; TRIACYLGLYCEROL;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BODY FAT DISTRIBUTION; BODY HEIGHT; BODY MASS; BODY WEIGHT; CALORIC INTAKE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FAT INTAKE; FEMALE; GLUCOSE BLOOD LEVEL; HOMEOSTASIS MODEL ASSESSMENT OF INSULIN RESISTANCE; HUMAN; HUMAN TISSUE; INFLAMMATION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INTRAABDOMINAL FAT; LIPID ANALYSIS; LIPID STORAGE; LIVER; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OBESITY; PANCREAS; PREVALENCE; PROTEIN BLOOD LEVEL; PROTEIN LOCALIZATION; SEX DIFFERENCE; SUBCUTANEOUS FAT; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

ADIPONECTIN; ADIPOSITY; ADULT; BODY MASS INDEX; DIETARY FATS; FEMALE; HUMANS; INSULIN RESISTANCE; INTRA-ABDOMINAL FAT; LIVER; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; OBESITY; OBESITY, ABDOMINAL; PANCREAS; SEX CHARACTERISTICS; SUBCUTANEOUS FAT, ABDOMINAL; WAIST CIRCUMFERENCE;

EID: 80052171769     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2011.114     Document Type: Article

References (39)

1. Unger RH. Minireview: weapons of lean body mass destruction: the role of ectopic lipids in the metabolic syndrome. Endocrinology 2003;144: 5159-5165. (Pubitemid 37476041)
2. Rasouli N, Molavi B, Elbein SC, Kern PA. Ectopic fat accumulation and metabolic syndrome. Diabetes Obes Metab 2007;9:1-10. (Pubitemid 44921036)
3. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 2002;346: 1221-1231.
4. Stranges S, Dorn JM, Muti P et al. Body fat distribution, relative weight, and liver enzyme levels: a population-based study. Hepatology 2004;39:754-763. (Pubitemid 38337655)
5. Thomas EL, Hamilton G, Patel N et al. Hepatic triglyceride content and its relation to body adiposity: a magnetic resonance imaging and proton magnetic resonance spectroscopy study. Gut 2005;54:122-127. (Pubitemid 40007230)
6. Eguchi Y, Eguchi T, Mizuta T et al. Visceral fat accumulation and insulin resistance are important factors in nonalcoholic fatty liver disease. J Gastroenterol 2006;41:462-469. (Pubitemid 43941913)
7. Lee Y, Hirose H, Ohneda M et al. Beta-cell lipotoxicity in the pathogenesis of non-insulin-dependent diabetes mellitus of obese rats: impairment in adipocyte-beta-cell relationships. Proc Natl Acad Sci USA 1994;91: 10878-10882.
8. Nolan CJ, Madiraju MS, Delghingaro-Augusto V, Peyot ML, Prentki M. Fatty acid signaling in the beta-cell and insulin secretion. Diabetes 2006;55 Suppl 2: S16-S23. (Pubitemid 44927028)
9. Tsochatzis E, Papatheodoridis GV, Archimandritis AJ. The evolving role of leptin and adiponectin in chronic liver diseases. Am J Gastroenterol 2006;101:2629-2640. (Pubitemid 44665263)
10. Expert Committee on the diagnosis and classification of diabetes mellitus. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 2003;26: 3160-3167.
11. Ross R, Léger L, Morris D, de Guise J, Guardo R. Quantification of adipose tissue by MRI: relationship with anthropometric variables. J Appl Physiol 1992;72:787-795.
12. Johnson D, Dixon AK, Abrahams PH. The abdominal subcutaneous tissue: computed tomographic, magnetic resonance, and anatomical observations. Clin Anat 1996;9:19-24. (Pubitemid 26011194)
13. Bahl M, Qayyum A, Westphalen AC et al. Liver steatosis: investigation of opposed-phase T1-weighted liver MR signal intensity loss and visceral fat measurement as biomarkers. Radiology 2008;249:160-166.
14. Kim HJ, Byun JH, Park SH et al. Focal fatty replacement of the pancreas: usefulness of chemical shift MRI. AJR Am J Roentgenol 2007;188: 429-432. (Pubitemid 46167745)
15. Schwenzer NF, Machann J, Martirosian P et al. Quantification of pancreatic lipomatosis and liver steatosis by MRI: comparison of in/opposed-phase and spectral-spatial excitation techniques. Invest Radiol 2008;43:330-337. (Pubitemid 351572210)
16. Lee SE, Jang JY, Lim CS et al. Measurement of pancreatic fat by magnetic resonance imaging: predicting the occurrence of pancreatic fistula after pancreatoduodenectomy. Ann Surg 2010;251:932-936.
17. Istituto Nazionale della Nutrizione. Tabelle di composizione degli alimenti. (National Institute of Nutrition: tables of nutritional composition.) Litho Delta: Milano, 1989 (in Italian).
18. Bonora E, Targher G, Alberiche M et al. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care 2000;23:57-63. (Pubitemid 30022895)
19. SPSS-X User's Guide, 2nd edn. McGraw-Hill: New York, 1986;147:755-63.
20. Jakobsen MU, Berentzen T, Sørensen TI, Overvad K. Abdominal obesity and fatty liver. Epidemiol Rev 2007;29:77-87. (Pubitemid 47229638)
21. Nielsen S, Guo Z, Johnson CM, Hensrud DD, Jensen MD. Splanchnic lipolysis in human obesity. J Clin Invest 2004;113:1582-1588. (Pubitemid 39071681)
22. Monzon JR, Basile R, Heneghan S, Udupi V, Green A. Lipolysis in adipocytes isolated from deep and superficial subcutaneous adipose tissue. Obes Res 2002;10:266-269. (Pubitemid 135688234)
23. Miyazaki Y, Glass L, Triplitt C et al. Abdominal fat distribution and peripheral and hepatic insulin resistance in type 2 diabetes mellitus. Am J Physiol Endocrinol Metab 2002;283:E1135-E1143. (Pubitemid 35340618)
24. Fabbrini E, Magkos F, Mohammed BS et al. Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity. Proc Natl Acad Sci USA 2009;106:15430-15435.
25. Pietiläinen KH, Rissanen A, Kaprio J et al. Acquired obesity is associated with increased liver fat, intra-abdominal fat, and insulin resistance in young adult monozygotic twins. Am J Physiol Endocrinol Metab 2005;288: E768-E774. (Pubitemid 40397213)
26. Lee JS, Kim SH, Jun DW et al. Clinical implications of fatty pancreas: correlations between fatty pancreas and metabolic syndrome. World J Gastroenterol 2009;15:1869-1875.
27. Heni M, Machann J, Staiger H et al. Pancreatic fat is negatively associated with insulin secretion in individuals with impaired fasting glucose and/or impaired glucose tolerance: a nuclear magnetic resonance study. Diabetes Metab Res Rev 2010;26:200-205.
28. van der Zijl NJ, Goossens GH, Moors CC et al. Ectopic fat storage in the pancreas, liver, and abdominal fat depots: impact on ß-cell function in individuals with impaired glucose metabolism. J Clin Endocrinol Metab 2011;96:459-467.
29. Hannukainen JC, Borra R, Linderborg K et al. Liver and pancreatic fat content and metabolism in healthy monozygotic twins with discordant physical activity. J Hepatol 2011;54:545-552.
30. Saisho Y, Butler AE, Meier JJ et al. Pancreas volumes in humans from birth to age one hundred taking into account sex, obesity, and presence of type-2 diabetes. Clin Anat 2007;20:933-942. (Pubitemid 350074312)
31. Pinnick KE, Collins SC, Londos C et al. Pancreatic ectopic fat is characterized by adipocyte infiltration and altered lipid composition. Obesity (Silver Spring) 2008;16:522-530. (Pubitemid 351328001)
32. Fraulob JC, Ogg-Diamantino R, Fernandes-Santos C, Aguila MB, Mandarim-de-Lacerda CA. A Mouse Model of Metabolic Syndrome: Insulin Resistance, Fatty Liver and Non-Alcoholic Fatty Pancreas Disease (NAFPD) in C57BL/6 Mice Fed a High Fat Diet. J Clin Biochem Nutr 2010;46:212-223.
33. Ronti T, Lupattelli G, Mannarino E. The endocrine function of adipose tissue: an update. Clin Endocrinol (Oxf) 2006;64:355-365.
34. Westerbacka J, Lammi K, Häkkinen AM et al. Dietary fat content modifies liver fat in overweight nondiabetic subjects. J Clin Endocrinol Metab 2005;90:2804-2809. (Pubitemid 40686327)
35. You M, Considine RV, Leone TC, Kelly DP, Crabb DW. Role of adiponectin in the protective action of dietary saturated fat against alcoholic fatty liver in mice. Hepatology 2005;42:568-577. (Pubitemid 41233649)
36. Hui JM, Hodge A, Farrell GC et al. Beyond insulin resistance in NASH: TNF-alpha or adiponectin? Hepatology 2004;40:46-54. (Pubitemid 38868922)
37. Musso G, Gambino R, Biroli G et al. Hypoadiponectinemia predicts the severity of hepatic fibrosis and pancreatic Beta-cell dysfunction in nondiabetic nonobese patients with nonalcoholic steatohepatitis. Am J Gastroenterol 2005;100:2438-2446.
38. Bugianesi E, Pagotto U, Manini R et al. Plasma adiponectin in nonalcoholic fatty liver is related to hepatic insulin resistance and hepatic fat content, not to liver disease severity. J Clin Endocrinol Metab 2005;90:3498-3504. (Pubitemid 41014319)
39. Sijens PE, Edens MA, Bakker SJ, Stolk RP. MRI-determined fat content of human liver, pancreas and kidney. World J Gastroenterol 2010;16: 1993-1998.